Language selection

Search

Patent 1042915 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1042915
(21) Application Number: 208720
(54) English Title: 2-IMINOMETHYL-3',4',5'-TRIMETHOXYCINNAMIC ACIDS AND ESTERS THEREOF, AND THEIR PRODUCTION
(54) French Title: ACIDES IMINOMETHYL-2 TRIMETHOXY-3',4',5' CINNAMIQUES ET LEURS ESTERS
Status: Expired
Bibliographic Data
(52) Canadian Patent Classification (CPC):
  • 260/515.1
  • 260/477.3
(51) International Patent Classification (IPC):
  • C07D 239/48 (2006.01)
  • C07D 239/49 (2006.01)
  • C07D 239/50 (2006.01)
(72) Inventors :
  • ALHEDE, BORGE (Not Available)
  • GELTING, NIELS (Not Available)
(73) Owners :
  • AKTIESELSKABET GEA (Not Available)
(71) Applicants :
(74) Agent: NA
(74) Associate agent: NA
(45) Issued: 1978-11-21
(22) Filed Date:
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data: None

Abstracts

English Abstract






ABSTRACT OF THE DISCLOSURE
2-Iminomethyl-3',4',5'-trimethoxycinnamic acids and
lower alkyl esters thereof are produced by reducing 3,4,5-tri-
methoxybenzylidene cyanoacetic acid, or the corresponding ester
thereof, in neutral or alkaline medium preferably in a pyridine
base as solvent.





Claims

Note: Claims are shown in the official language in which they were submitted.


THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for the production of 2-iminomethyl-3',
4',5'-trimethoxycinnamic acid and esters thereof of the formula


Image I


wherein R is a hydrogen atom or an alkyl group having 1-4 carbon
atoms, which comprises reducing 3,4,5-trimethoxybenzylidene-
cyanoacetic acid or an ester thereof of the formula

Image II

wherein R is as hereinbefore defined in a neutral or alkaline
medium.
2. A process according to claim 1, characterized in
that the reduction is carried out using a pyridine base as a
solvent.
3. A process as claimed in claim 2 in which the
pyridine base is picoline.
4. A process as claimed in claim 1 in which R is
methyl or ethyl.


Description

Note: Descriptions are shown in the official language in which they were submitted.


Z9~5
This invention relates to 2-iminomethyl-3',4',5'-tri-
me-thoxycinnamic acid and esters thereof having the formula
CH O
~ COOR
~ I ,,
3 ~ ~ CH = C
\ CH = NH
wherein R is a hydrogen atom or an alkyl group having 1-4
carbon atoms, being useful as intermediates in the produc-
tion of 2,4-diamino-5-(3',4',5'-trimethoxybenzyl)-pyrimi-
dine. The latter is a known compound, also called trimetho- i
prim, and has the formula
CH~O

3 ~ CH2 ~ ~ 2
CH30 NH2
Trimethoprim shows a useful antibacterial and sulphon-
amide-potentiating effect.
lo The inven-tion also relates to a process for the pro-
duction of the compounds of formula I.
It is known that the ethyl ester of 3,4,5-trimethoxy-
benzylidene-cyanoacetic acid having the formula
CH O
~ . COOC2H5
3 ~ CH = IC III
~ ..
CN
~ CH30
can be reduced in acid medium to form 3,4,5-trimethoxybenzyl-
cyanoacetic acid ethyl ester having the formula
CH O
,~ COOC2H5
; 3 ~~ CH2 - CH IV
.\ CN

-- 2 --



-

L04~
as a colourless oil, and that the said compound can be con-
densed with guanidine to form 2,4-diamino-6-hydroxy-5-(3',
; 4',5'-trimethoxybenzyl)-pyrimidine having the formula
CH30 H0

CH~0. ~ CH2 ~ ~ ~ 2

CH30 NH2
which again can be converted into trimethoprim by removal
of the 6-hydroxy group.
The said known method is disadvantageous in that re-
duction of the compound of formula III yields a compound,
formula IV 9 which owing to its physical properties is only
very difficultly recovered in an even tolerably pure s-tate.
lo This means that the compound of ~ormula V, which is produced
by condensation wi-th guanidine, and/or the trimethoprim pro-
duced therefrom, has to be subjected to further cost-adding
purifications in order to get a pharmaceutically acceptable
product
The object of the present invention is to overcome the
said disadvantage by providing an intermediate suitable ~or
the production o~ trimethoprim, which is easily recovered in
a pure state by crystallisation, instead of the compound of
formula IV.
It has surprisingly been found that this is possible,
when using, as an intermediate in the production of trime-
thoprim, hitherto unknown 2-iminomethyl-3',4',5'-trime-th-
oxycinnamic acid compounds which according to the inven-
tion are characterized in having the formula I, wherein R
is a hydrogen atom or an alkyl group having 1-4 c~rbon atoms.
According to the invention, the compounds of ~ormula I
can be produced under mild conditions, at room temperature,




. . . ......

~L~4Z9~5
by reduction in a neutral or alkaline medium of 3,4,5-trimethoxy-
benzylidene-cyanoacetic acid or an ester thereof of the formula


CH30 COOR


CH30 ~/ r CH =f II

CN
CH3O

wherein R is a hydrogen atom or an alkyl group having 1-4 carbon
atoms. The resulting compound of formula I can be isolated in
crystalline form, and it is recovered in quantitative yield. It
is thus extremely pure and will give extremely pure products when
used as an intermediate in the production of trimethoprim.
The reduction of the compound of formula II may be
carried out in any suitable solvent, such as ethanol, but according
to the invention particularly good results are obtained by using
pyridine bases, preferably picoline, as a solvent.
Trimethoprim can be produced from the present compounds
of formula I by first condensing with guanidine to obtain the
formerly mentioned 2.4-diamino-6-hydroxy-5-~3',4',5'-trimethoxy-

benzyl)-pyrimidine of formula V, which in known manner is converted
into trimethoprim by removing the 6-hydroxy group.
In the following the production and use of the present
intermediates is illustrated by some Examples.
Example 1
2-Iminomethyl-3',4',5'--trimethoxycinnamic acid ethyl ester

.
58.2 grams (0.2 mole) of 3,4,5-trimethoxy-benzylidene-
cyanoacetic acid ethyl ester and 1 gram of Pd/C ~10%) in





-" ~L0~29~s
380 ml of 2-picoline were s-tirred at room temperature under
a hydrogen pressure of 10 atmospheres, until no more hydro-
gen was consumed, when stirring was continued for further
two hours. The catalyst was filtered off, and the picoline
was evaporated in va uo. The residue was dissolved in 150
ml of hot ethanol. By cooling, 58.5 grams (100%) of 2-~ino-
methyl-3',4',5'-trimethoxycinnamic acid ethyl ester with
melting point 48-49C crystallized.

lo Example 2
2-Iminometh~1-3',4',5'-trimethoxycinnamic acid ethyl ester
8,73 grams (0.030 mole) of 3,4,5-trimethoxy-benzylidene-
cyanoacetic acid ethyl ester were dissolved in 130 ml o,f an-
hydrous e-thanol. There was added 0.1 gram palladium on car-
bon (10%), and the mixture was placed in a hydrogenation au-
toclave. Hydrogen was supplied to a pressure of 11 atmos-
pheres, and the reaction mixture was left with stirring, un-
til one equivalent of hydrogen had been consumed, when the
reaction stopped. Pouring out of the reaction mixture dis-
closed that a white subs-tance had crystallized. The mixture
was heated to 50C, resulting in the said white substance
dissolvin~; the catalyst was filtered off, and 6.31 grams of
the white product crystallized by cooling. Partial evapora-
tion of the paren-t lye yielded further 2.29 grams, making a
total yield of 8.60 grams, 97.0%. After recrystallization
from anhydrous eth~nol, the compound melted at 48-49C.
Use of the intermediate in the production of trimetho-
prim is illustra-ted by the following Examples.

Example 3
2,4-Diamino-6-hydrox~-5-(31,4',~5'-trimeth~ybenzyl)~ imidine

42~
To a mixture of 14.7 grams (0.050 mole) of the ethyl
ester of 2-iminome-thyl-3',4l,5'-trimethoxycinnamic acid and
4.78 grams (0.050 mole) of guanidine hydrochloride in 150
ml of toluene were added 5.4 grams (0.10 mole) o~ sodium
methoxide. The reaction mixture was refluxed for 11 hours.
The toluene was removed in vacuo by suction, and the resi-
due was dissolved in dilute aqueous sodium hydroxide. Acetic
acid was added to the solution to pH 4-6, resulting in the
precipitation of an almost white product. The produc-t was
lo removed by filtration, washed with water, and dried7 Yield r
13.2 grams, 86.3%.
r
Example 4
a) 6-Chloro-2 4-diamino-5-(3' L4~ ,5'-trimethox;ybenz~ pyri-
_idine
A mixture of 15.6 grams (0.051 mole) of 2,4-diamino-6-
hydroxy-5-(3',4',5'-trimethoxybenzyl)-pyrimidine and 75 mI
of phosphorus oxychloride was heated on a steam bath ~or
three hours. Excess of phosphorus oxychloride was removed
i
in vacuo by filtration with suction. Ice was added to the
residue, and potassium carbonate was added to pH 8. The pre- P
cipitated substance was filtered off, washed with water, and
dried. Yield 14.1 grams~ 85.2%.
After recrystallization from nitromethane, the compound
melted at 218.5-220.5C.
b) 2,4-Diamino-5-(3',4't5'-trimethoxybenzYl)-pyrimidine r
~ 8.11 grams (0.025 mole) of 6-chloro-2,4-diamino-5-(3', It
`~ 4',5'-trime-thoxybenzyl)-pyrimidine were suspended in 300 ml
of 96% ethanol, and 0.6 gram o~ palladium on carbon (5%) was
added. Hydrogen at atmospheric pressure was supplied to the
suspension. After consumption of one equivalent of hydrogen,


-- 6 --

~ Z~L5
the reaction stopped. The reaction mixture was evaporated
almost to dryness, and dilute acetic acid was added. The ca-
talyst was removed by filtration. Aqueous sodium hydroxide
was added to make the parent lye alkaline, whereby 2,4-dia- ;mino-5-(3',4',5'-trimethoxybenzyl)-pyrimidine precipitated.
The compound was removed by filtration, washed with water,
and dried. Yield 6.59 grams, 90.9%.
After recrystallization from ethanol, the compound
melted at 200.5-202.0C.
lo f
Example 5
a) 6-Chloro-2,4-diamino-5-(3' 4' ~-trimethoxybe
midine
A mixture of 15.6 grams (0.051 mole) of 2,4-diamino-6-
hydroxy-5-(3t,4',5'-trimethoxybenzyl)-pyrimidine and 75 ml
of phosphorus oxychloride was heated on a steam bath for
I four hours. Excess of phosphorus oxychloride was removed
I in vacuo by suction. Ice was added to the residue, and po-
tassium carbonate was added to pH 8. The precipitated com-
pound was sucked off, washed with water, and dried. Yield
14.9 g, 90.0%. ~
b) 2,4-Diami~o-6-hydrazino-~-(3'~4' ~ l,
pyrimidine
16.2 grams (0.050 mole) of 6-chloro-2,4-diamino-5-(3'-
4',5'-trimethoxybenzyl)-pyrimidine were suspended in 85 ml
of hydrazine hydrate. The mixture was refluxed to dissolve
~' the chlorinated compound. After an hour and a half, the
reaction mixture was cooled in ice water and the hydrazino
derivative crystallized. The compound was filtered from the
parent lye and washed with cold methanol on the filter.
Yield 15.1 grams, 94~. Mel ing point 159-162C.




. . .

~Z~S
c) 2,4-Diam no-5-(3'~4'.5'-trimethox~benzyl)-pyrimidine s
8.0 grams (0.025 mole) of 2,4-diamino-6-hydrazino-5-
(3',4',5'-trimethoxybenzyl)-pyrimidine were suspended in
100 ml of water. The mixture was heated to 100C, at which
temperature 250 ml of a 0.40 M aqueous solution of CuS04 ~;
were added dropwise during 3/4 hour. After the said addition,
-the mixture was cooled, and free Cu, precipitated during the
reaction, was filtered off. Ammonia was added to make the
parent lye alkaline, resulting in the precipitation of a
lo greyish green substance, which was removed by filtration,
and aqueous sodium hydroxide was added to the parent lye,
whereby a further amount of the greyish green substance was
precipitated and also filtered off. The two fractions of
substance were recrystallized from H20 and activated carbon
to yield 6.2 grams, 85.5%, of 2,4-diamino-5-(3i,4~,5'-tri-
methoxybenzyl)-pyrimidine with melting point 199.5-201.5C.



~.




.

- 8 -

Representative Drawing

Sorry, the representative drawing for patent document number 1042915 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 1978-11-21
(45) Issued 1978-11-21
Expired 1995-11-21

Abandonment History

There is no abandonment history.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
AKTIESELSKABET GEA
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Drawings 1994-05-24 1 13
Claims 1994-05-24 1 27
Abstract 1994-05-24 1 17
Cover Page 1994-05-24 1 23
Description 1994-05-24 7 289